Prostate Cancer: New Horizons in Research and Treatment - Couverture souple
Livre 39 sur 78: Developments in Oncology
Synopsis
Pathology of prostate cancer.- Prostate cancer susceptibility genes: Many studies, many results, no answers.- Molecular profiling in prostate cancer.- Chromosomal deletions and tumor suppressor genes in prostate cancer.- Role of eicosanoids in prostate cancer progression.- Contribution of the androgen receptor to prostate cancer predisposition and progression.- Regulation of apoptosis in prostate cancer.- On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis.- Metastasis suppression in prostate cancer.- The urokinase-type plasminogen activator system in prostate cancer metastasis.- Angiogenesis in prostate cancer: Biology and therapeutic opportunities.- Integrins and prostate cancer metastases.- Prostate carcinoma skeletal metastases: Cross-talk between tumor and bone.- Signal transduction targets in androgen-independent prostate cancer.- The diet, prostate inflammation, and the development of prostate cancer.- Prostate cancer diagnosis, staging and survival.- Surgery for prostate cancer: Rationale, technique and outcomes.- The future of cancer imaging.- Antisense therapy: Current status in prostate cancer and other malignancies.- Antiangiogenesis therapeutic strategies in prostate cancer.- Chemoprevention of prostate cancer.- Prostate brachytherapy.- Fast neutron irradiation for prostate cancer.- Prostate cancer gene therapy: Past experiences and future promise.- Vitamin D-related therapies in prostate cancer.- Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
